{"name":"OSI Pharmaceuticals","slug":"osi-pharmaceuticals","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Combination carboplatin and paclitaxel","genericName":"Combination carboplatin and paclitaxel","slug":"combination-carboplatin-and-paclitaxel","indication":"Non-small cell lung cancer","status":"phase_3"}]}],"pipeline":[{"name":"Combination carboplatin and paclitaxel","genericName":"Combination carboplatin and paclitaxel","slug":"combination-carboplatin-and-paclitaxel","phase":"phase_3","mechanism":"This combination uses carboplatin to cross-link DNA and paclitaxel to stabilize microtubules, together inducing cancer cell death through complementary cytotoxic mechanisms.","indications":["Non-small cell lung cancer","Ovarian cancer","Breast cancer"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxNQXZ1OUZIM3BJNEw3THNMd19oZzV3UU1zSlcxRm1yUldXTTY2SGhkQjRfLUhzWm9zUkU3ZkQwRXJWVnAxTFNxcDEwemtQeGJOM2Q4MFhZQ2p5Mm84S0lCNTIxQ2R3YjB6SGM3NmswNl81dHR3REYyN29HX0Z6SXpuMg?oc=5","date":"2026-03-23","type":"pipeline","source":"pharmatimes.com","summary":"IsomAb appoints Philip Brainin as CEO - pharmatimes.com","headline":"IsomAb appoints Philip Brainin as CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxNME1fYUJ2U1lPMFFEVG5uUEIwRHVzUW9GS0UwLWlWOWlBakZOQVNWOXdpTUtEcUdoS2JaSlBFVUpxYmdJUkFNdUp6ZlRYNG1nX1Izek10UEQ3MU5nYldvR2R1RzlMSmx4TTZyWktZaTgxcVg5NXRQVGFRUWMzdFdoSEUtUnJVWnhkYnlhWGNkSmxsR2lpcFVzNHBEcUdKWnYwRmRnLXBlOU14aG9iXzBkbDRBa1poQkNXRGU3VlpBMHRfdw?oc=5","date":"2019-12-04","type":"patent","source":"IPWatchdog.com","summary":"OSI Pharmaceuticals Decision Has Limited Use in Supporting Patentability of Method of Treatment Claims - IPWatchdog.com","headline":"OSI Pharmaceuticals Decision Has Limited Use in Supporting Patentability of Method of Treatment Claims","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxObnJfSHF6OGVJLXRRTm4zUko1ZXpZX0pzdVZzNlZBVVpXRW9EVnZPN2RZSmJRWVVTa0lob0lwTUttWHlTbnhGR05oYnZKTC1hSHhnQ2hFRHZNa1pCdFQwYTdpb3JfZUxDTGFiQWNsWFlGWWxOajVEQXpBZFVVTU5nWVFYS0w2YkhyS0J4Qm1Vb0p4TEZzNlV5UklTelYtWnllcVdYUkpHOXJ0T0dfZ01WQi1RWHNjcjhUajF5dg?oc=5","date":"2018-04-08","type":"pipeline","source":"Eli Lilly","summary":"Lilly and OSI Pharmaceuticals Announce Licensing Agreement - Eli Lilly","headline":"Lilly and OSI Pharmaceuticals Announce Licensing Agreement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxNeXc2VjJ2aFRjeW5pbzRYd2dVRzJpeUxpWWozeURackZkYlF3Q1UyZHZXajJFdUIzenJwSk9ZeXBmLTdEMWNWemt0UHRzb1RFLXFaWklOLV82ekp0MGZObFkwM3h2cVdtOUtjc1hZc0ZLWFBULTUyTEFMVUc5NnRmYW55RUxwd3VBLTN4cnU3eUVZbjI1QmItNkZUdVEwWFlpSXR6czFnS3FWOXcyT3NR?oc=5","date":"2016-06-08","type":"trial","source":"BioPharma Dive","summary":"Genentech/OSI fined $67 million for skewing cancer-drug survival data - BioPharma Dive","headline":"Genentech/OSI fined $67 million for skewing cancer-drug survival data","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxOOGxhWGpKa1ZzSWEzQTBLSVNxd3BJN0p6bTE2ZnVqUTZoVnhCRXl5U3h4bElnU1dRLWRXOWFKcDkzS0xnOWhrRUJ0MkNCYlNNbnM4VXZUMk5QNEpiY2R4aUdxVmJMQlhFeEdQMlEtNnEwQXVpc0xFZlZBTzhkOU9CQg?oc=5","date":"2016-06-07","type":"pipeline","source":"CNN","summary":"Companies must pay $67 million in settlement over cancer drug claims - CNN","headline":"Companies must pay $67 million in settlement over cancer drug claims","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPRjdDMTk4RE4za2hMSXZXVnJQbUcxeno1ekRFbFJQOHE3dDZzU3RhTW9sU3htUHFSeWRqWFl6M0F0VUNzN0QxQXZVUkRtanh3c3BQbUhvR0F6aVNCUFZScno4Tm4wT0c4QXBDcGxrbFZaYVVNUjU4S3F6aVNfWGpzM2JOY0M2LWowOGJBeW5zSzB1T3ktWnRjbXFnTnRjNHBOREdVc1VVamtMdw?oc=5","date":"2016-06-07","type":"pipeline","source":"Fierce Pharma","summary":"UPDATE: Genentech, OSI shell out $67M to settle cancer-drug marketing claims: DOJ - Fierce Pharma","headline":"UPDATE: Genentech, OSI shell out $67M to settle cancer-drug marketing claims: DOJ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNbkRWSHdCN3JRT3pta010OXkwc2syaVNIR0ZBeGlYRk01djlwbzQ0YTBRSkNCd3hwS3lXcm1fbExFcVdkenFSLVJuekFFb0ltb2pJRTFHTEpsdjZRQ3VBUjFNM09CQ2F1RWNtXy1KTkJ2OGlkNm5DQUVyOWIzNV9aa3praWFVVTVLNDBmN0tSWFRQSGkwR3JfaVpnTFM?oc=5","date":"2015-03-10","type":"pipeline","source":"Cold Spring Harbor Laboratory","summary":"LI pharma executive joins Cold Spring Harbor Laboratory as General Counsel - Cold Spring Harbor Laboratory","headline":"LI pharma executive joins Cold Spring Harbor Laboratory as General Counsel","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxQelZyYnR2YzlBaVZzVkhhdE9BOWplWVZzUXNsdUZwd3hEdDEzWUNqTWJ6c1dxeko5bl9QaWdPcVpqTC1ldDNxbXN5SFBkR0RHc0RuZmZqbzdLNm5mbGlDb3RIc0c5cXNOVGltbXN1cGpiRm5mRGwwcFFfZmZ2d1N0dGZXb3U2Y0VsSkE?oc=5","date":"2014-02-21","type":"earnings","source":"Long Island Business News","summary":"OSI Pharmaceuticals' former Melville headquarters sold - Long Island Business News","headline":"OSI Pharmaceuticals' former Melville headquarters sold","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQOWxCRy1MQWdPbDdJX09LYjdKcVQ1YW52MHM5aUNUemk5eUVNZVRZcDhZV3VJRVgxZmx1dy01c1VwMHNjNW0ySmc1RU1pakVrVkJTbUx0cWdmVzZjUXZ0NDRGZkEtcGFQblVDSmpYcVlLRklQWjRFLWN1QzNXUUhZa0phdmZFbEFGOGdqQmp3?oc=5","date":"2011-02-21","type":"pipeline","source":"Newsday","summary":"Executive Suite: Naoki Okamura, OSI Pharmaceuticals - Newsday","headline":"Executive Suite: Naoki Okamura, OSI Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTFBubWE5WWY3MTI0TnVPNy0zMGxqR181VWM5UWNpZmE3ek5rV29GSXJkWndNS2JHZ3NCU2VuRmNqMF9DeWNzU2xLSXRnbWxTY080TUY4WmZ3SW15S3BjeF96OWdiZVlXZXJOTFJsN3JJM1Q4Mk1ScTdhcXpNXzhOUQ?oc=5","date":"2010-05-17","type":"deal","source":"Pharmafile","summary":"Astellas set to acquire OSI Pharmaceuticals for $4bn - Pharmafile","headline":"Astellas set to acquire OSI Pharmaceuticals for $4bn","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE12QllmVm9LTTJlcllkNm9WUlV5Yzd4aXUzeWE4QzRDa3FySGltdHVETklNanB3dTc4SkpjcU5sREk4ZF9mMTRwWmgxVVhDR1Vkd2VVRjdHa3FVLXF5eVc0Rmwxdi1vU1c5enJkLWdHcnRiejRVblE?oc=5","date":"2005-08-29","type":"deal","source":"C&EN","summary":"OSI to Acquire Eyetech Pharma - C&EN","headline":"OSI to Acquire Eyetech Pharma - C&EN","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTFBiSVUxbFNacXoyOUJUMjhyLVZua3BubXY5RWJJYnVlWF8ybndoQ3BzNTB1WmsxMnlybm1yRk9JX283aExGTm9VMllUOGM2WDhqXy1MNVVXMnI0aHBOSGc?oc=5","date":"2002-02-25","type":"pipeline","source":"WSJ","summary":"Best 3-Year Performer OSI Pharmaceuticals - WSJ","headline":"Best 3-Year Performer OSI Pharmaceuticals","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":3,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":null,"revenuePeriod":null,"revenueHistory":[],"grossProfit":null,"grossProfitHistory":[],"rdSpend":null,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":null,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":null,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}